The
report "Genital Warts (Condylomata Acuminata) - Pipeline Review,
H1 2016 ", has been prepared based on an in-depth market
analysis with inputs from industry experts.
Global
Markets Directs, Genital Warts (Condylomata Acuminata) - Pipeline
Review, H1 2016, provides an overview of the
Genital Warts (Condylomata Acuminata)
pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Genital Warts (Condylomata Acuminata), complete with
analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report
also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases. Additionally, the report provides an
overview of key players involved in therapeutic development for
Genital Warts (Condylomata Acuminata) and features dormant and
discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report @
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Genital Warts (Condylomata Acuminata)
-
The report reviews pipeline therapeutics for Genital Warts
(Condylomata Acuminata) by companies and universities/research
institutes based on information derived from company and
industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Genital Warts (Condylomata
Acuminata) therapeutics and enlists all their major and minor
projects
-
The report assesses Genital Warts (Condylomata Acuminata)
therapeutics based on drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Genital Warts (Condylomata Acuminata)
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Genital Warts (Condylomata Acuminata)
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Genital Warts (Condylomata Acuminata) pipeline depth and focus of
Indication therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Browse All reports Of this
Category: www.marketresearchreports.biz/category/38
Table
of Content :
Table
of Contents 2
List
of Tables 5
List
of Figures 6
Introduction
7
Global
Markets Direct Report Coverage 7
Genital
Warts (Condylomata Acuminata) Overview 8
Therapeutics
Development 9
Pipeline
Products for Genital Warts (Condylomata Acuminata) - Overview 9
Genital
Warts (Condylomata Acuminata) - Therapeutics under Development by
Companies 10
Genital
Warts (Condylomata Acuminata) - Pipeline Products Glance 11
Clinical
Stage Products 11
Early
Stage Products 12
Genital
Warts (Condylomata Acuminata) - Products under Development by
Companies 13
Genital
Warts (Condylomata Acuminata) - Companies Involved in Therapeutics
Development 14
Agilvax,
Inc. 14
Aviragen
Therapeutics, Inc. 15
Biogenomics
Limited 16
BioMAS
Ltd. 17
Foamix
Pharmaceuticals Ltd. 18
G&E
Herbal Biotechnology Co., Ltd. 19
Helix
BioPharma Corp. 20
Laboratories
Ojer Pharma S.L. 21
LEO
Pharma A/S 22
Novan,
Inc. 23
Novartis
AG 24
Tamir
Biotechnology, Inc. 25
Zydus
Cadila Healthcare Limited 26
Genital
Warts (Condylomata Acuminata) - Therapeutics Assessment 27
Assessment
by Monotherapy Products 27
Assessment
by Combination Products 28
Assessment
by Target 29
Assessment
by Mechanism of Action 31
Assessment
by Route of Administration 33
Assessment
by Molecule Type 35
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
us:
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment